Market Cap (In JPY)
7.45 Billion
Revenue (In JPY)
12.3 Billion
Net Income (In JPY)
338.26 Million
Avg. Volume
40.68 Thousand
- Currency
- JPY
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 325.0-553.0
- PE
- -
- EPS
- -
- Beta Value
- 0.301
- ISIN
- JP3974530002
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Kazuhiro Hatano
- Employee Count
- -
- Website
- https://www.linical.co.jp
- Ipo Date
- 2008-10-27
- Details
- Linical Co., Ltd. provides drug development services primarily in the areas of oncology and central nervous system to pharmaceutical companies worldwide. The company offers drug development consulting services, such as market analysis of products in development, regulatory affairs consultation support, and licensing support. It also provides clinical research and development, and contract medical affairs services, including front-end services comprising project management, monitoring, quality control, vendor management, auditing, and clinical research secretariat; and back-end services, which include data management, bio statistical analysis, medical writing, pharmacovigilance, and medical management. The company was incorporated in 2005 and is headquartered in Osaka, Japan.
More Stocks
-
601818
-
600284
-
300444
-
VEZVeganz Group AG
VEZ
-
KAEF
-
0288WH Group Limited
0288
-
CANDOURCANDOUR TECHTEX LIMITED
CANDOUR
-
OMIC